2,435
Views
23
CrossRef citations to date
0
Altmetric
Original Articles

Clinical evaluation and treatment of chronic bowel symptoms following cancer in the colon and pelvic organs

, , , , , & show all
Pages 776-781 | Received 15 Aug 2018, Accepted 11 Dec 2018, Published online: 30 Jan 2019

References

  • Andreyev HJ, Davidson SE, Gillespie C, et al. Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Gut. 2012;61:179–192.
  • Yde J, Larsen HM, Laurberg S, et al. Chronic diarrhoea following surgery for colon cancer-frequency, causes and treatment options. Int J Colorectal Dis. 2018;33:683–694.
  • Emmertsen KJ, Laurberg S. Impact of bowel dysfunction on quality of life after sphincter-preserving resection for rectal cancer. Br J Surg. 2013;100:1377–1387.
  • Emmertsen KJ, Laurberg S. Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer. Ann Surg. 2012;255:922–928.
  • Harris V, Benton B, Sohaib A, et al. Bile acid malabsorption after pelvic and prostate intensity modulated radiation therapy: an uncommon but treatable condition. Int J Radiat Oncol Biol Phys. 2012;84:e601–e606.
  • Danielsson A, Nyhlin H, Persson H, et al. Chronic diarrhoea after radiotherapy for gynaecological cancer: occurrence and aetiology. Gut. 1991;32:1180–1187.
  • Phillips F, Muls AC, Lalji A, et al. Are bile acid malabsorption and bile acid diarrhoea an important cause of diarrhoea complicating cancer therapy? Colorectal Dis. 2015;17:730–734.
  • Wedlake L, Thomas K, Lalji A, et al. Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire. Clin Ther. 2009;31:2549–2558.
  • Gatta L, Scarpignato C. Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Aliment Pharmacol Ther. 2017;45:604–616.
  • Mottacki N, Simren M, Bajor A. Review article: bile acid diarrhoea – pathogenesis, diagnosis and management. Aliment Pharmacol Ther. 2016;43:884–898.
  • Gupta A, Muls AC, Lalji A, et al. Outcomes from treating bile acid malabsorption using a multidisciplinary approach. Support Care Cancer. 2015;23:2881–2890.
  • Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32:920–924.
  • Walters JR. Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy. Nat Rev Gastroenterol Hepatol. 2014;11:426–434.
  • Borghede MK, Schlutter JM, Agnholt JS, et al. Bile acid malabsorption investigated by selenium-75-homocholic acid taurine ((75)SeHCAT) scans: causes and treatment responses to cholestyramine in 298 patients with chronic watery diarrhoea. Eur J Intern Med. 2011;22:e137–e140.
  • Andreyev HJ, Vlavianos P, Blake P, et al. Gastrointestinal symptoms after pelvic radiotherapy: role for the gastroenterologist? Int J Radiat Oncol Biol Phys. 2005;62:1464–1471.
  • Steineck G, Skokic V, Sjoberg F, et al. Identifying radiation-induced survivorship syndromes affecting bowel health in a cohort of gynecological cancer survivors. PLoS One. 2017;12:e0171461.
  • Steineck G, Sjoberg F, Skokic V, et al. Late radiation-induced bowel syndromes, tobacco smoking, age at treatment and time since treatment - gynecological cancer survivors. Acta Oncol. 2017;56:682–691.
  • Petrone P, Sarkisyan G, Fernandez M, et al. Small intestinal bacterial overgrowth in patients with lower gastrointestinal symptoms and a history of previous abdominal surgery. Arch Surg. 2011;146:444–447.
  • Andreyev J. Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients. Lancet Oncol. 2007;8:1007–1017.
  • Grace E, Shaw C, Whelan K, et al. Review article: small intestinal bacterial overgrowth-prevalence, clinical features, current and developing diagnostic tests, and treatment. Aliment Pharmacol Ther. 2013;38:674–688.
  • Mitchell JE, Breuer RI, Zuckerman L, et al. The colon influences ileal resection diarrhea. Dig Dis Sci. 1980;25:33–41.
  • Merrick MV, Eastwood MA, Ford MJ. Is bile acid malabsorption underdiagnosed? An evaluation of accuracy of diagnosis by measurement of SeHCAT retention. Br Med J (Clin Res Ed). 1985;290:665–668.
  • Wilcox C, Turner J, Green J. Systematic review: the management of chronic diarrhoea due to bile acid malabsorption. Aliment Pharmacol Ther. 2014;39:923–939.
  • Pattni S, Walters JR. Recent advances in the understanding of bile acid malabsorption. Br Med Bull. 2009;92:79–93.
  • Wedlake L, A’Hern R, Russell D, et al. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2009;30:707–717.
  • Damsgaard B, Dalby HR, Krogh K, et al. Long-term effect of medical treatment of diarrhoea in 377 patients with SeHCAT scan diagnosed bile acid malabsorption from 2003 to 2016; a retrospective study. Aliment Pharmacol Ther. 2018;47:951–957.
  • Hill P, Muir JG, Gibson PR. Controversies and recent developments of the low-FODMAP diet. Gastroenterol Hepatol (N Y). 2017;13:36–45.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.